New Strong Buy Stocks for December 29th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:


Sapiens International Corporation N.V.


SPNS

: This company that provides software solutions for the insurance and financial services industries has seen the Zacks Consensus Estimate for its current year earnings increasing 7.7% over the last 60 days.


Carpenter Technology Corporation


CRS

: This specialty metals company has seen the Zacks Consensus Estimate for its current year earnings increasing 21.1% over the last 60 days.


DHT Holdings, Inc.


DHT

: This operator of crude oil tankers has seen the Zacks Consensus Estimate for its current year earnings increasing 144.4% over the last 60 days.


Docebo Inc.


DCBO

: This company that provides a cloud-based learning management system for training has seen the Zacks Consensus Estimate for its current year earnings increasing 58.3% over the last 60 days.


Entera Bio Ltd.


ENTX

: This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 14.6% over the last 60 days.

You can see

the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

.


Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.


Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report


To read this article on Zacks.com click here.


Zacks Investment Research

If You Liked This Article Click To Share

Biotech